Aug 12, 2026 06:50AM
Aug 5, 2026 06:50AM
May 13, 2026 06:50AM
May 6, 2026 06:50AM
Mar 18, 2026 06:50AM
Mar 11, 2026 06:50AM
Mar 9, 2026 06:00AM Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)
Jan 30, 2026 09:50AM
Jan 30, 2026 09:47AM
Jan 5, 2026 06:50AM
Jan 5, 2026 06:50AM
Dec 17, 2025 06:50AM
Dec 17, 2025 06:50AM
Nov 13, 2025 06:50AM Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
Nov 6, 2025 06:50AM
Nov 3, 2025 04:30PM
Nov 3, 2025 04:30PM
Oct 17, 2025 06:59AM
Oct 17, 2025 06:58AM
Sep 2, 2025 06:50AM
Aug 14, 2025 06:50AM Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
Aug 7, 2025 12:53PM
Jul 21, 2025 06:50AM
Jul 21, 2025 06:50AM
Jun 30, 2025 06:51AM
Jun 30, 2025 06:50AM
May 14, 2025 06:50AM
May 9, 2025 06:50AM Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results
May 5, 2025 06:50AM
Mar 24, 2025 06:50AM
Mar 17, 2025 06:50AM
Mar 10, 2025 06:50AM
Feb 4, 2025 06:50AM
Dec 23, 2024 06:52AM
Dec 23, 2024 06:50AM Protalix BioTherapeutics Issues 2025 Letter to Stockholders
Dec 9, 2024 06:30AM
Nov 14, 2024 06:50AM
Nov 7, 2024 06:50AM
Oct 25, 2024 07:18AM
Sep 16, 2024 08:35AM
Sep 4, 2024 06:50AM
Sep 3, 2024 06:51AM Protalix BioTherapeutics (PLX) Repays Outstanding Senior Secured Convertible Promissory Notes
Sep 3, 2024 06:50AM
Aug 14, 2024 06:50AM
Aug 7, 2024 06:50AM
Jun 13, 2024 06:50AM
May 29, 2024 08:38AM
May 10, 2024 06:50AM
May 3, 2024 06:50AM Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
Mar 14, 2024 06:50AM

329,005 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All